This summer’s IPO by Artiva Biotherapeutics Inc. highlighted early stage efforts with natural killer cells in autoimmune disease, where a handful of companies are advancing programs. The firm raised ...

Billions of years of evolution have made modern cells incredibly complex. Inside cells are small compartments called ...

Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer cell ...

Researchers analyzed airway and blood samples from children with respiratory syncytial virus (RSV). They discovered elevated ...

The CDC recommends most adults log at least seven hours of sleep per night, putting emotional well-being at the top of the ...

Trinity College Dublin researchers, based at St James's Hospital have provided important insights into the behavior and ...

Trinity College Dublin researchers, based at St James's Hospital have provided important insights into the behavior and metabolic function of a previously largely unknown, but crucial 'natural killer' ...

INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company targeting microglial activation and neuroinflammation as a cause of Alzheimer’s Disease (AD), today ...

Trinity College Dublin researchers based at St James's Hospital have provided important insights into the behavior and ...

The data shed more light on how patients in the real world are faring after CAR T-cell treatment, says Sarju Ganatra.

Full abstracts accepted as poster presentations will also be included in the special CTAD edition of the Journal of Prevention of Alzheimer’s Disease (JPAD), the official journal of the CTAD ...